Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
In a bid to increase its liquidity, real estate investment trust (REIT) Kennedy Wilson Holdings, Inc (KW - Snapshot Report) recently announced that it has priced 7.5 million shares at $13.00 a share. To cover the over-allotment options, Kennedy Wilson also plans to offer a 30-day option to the underwriters for purchasing an additional 1,125,000 shares.The offering is expected to close on July 24, 2012.
The company expects to generate net proceeds of approximately $92.4 million from the offering after the underwriting discount and estimated offering expenses. The net proceeds from the equity offer will be used to repay debt outstanding under its unsecured revolving credit facility, to fund property acquisitions and for general corporate purposes.
Kennedy Wilson reported first quarter 2012 net loss of $3.4 million or 7 cents per share compared to a net loss of $1.0 million or 2 cents per share in the year-ago quarter. As of March 31, 2012, the company’s cash position stood at $122.3 million versus $115.9 million in the prior quarter.
Headquartered in Beverly Hills, California, Kennedy Wilson offers a widearray of real estate services including auction, conventional sales, property services, and research and investment management with 23 offices in the U.S., Europe and Japan. The company continues to witness opportunities to grow its cash flow through reinvestment of the return of capital and gains realized from dispositions.
Kennedy Wilson currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We have a long-term Neutral recommendation on the stock. One of its competitors, CBRE Group, Inc (CBG - Analyst Report) also holds a Zacks #3 Rank.
Get the full Analyst Report on CBG - FREE
Get the full Snapshot Report on KW - FREE